Literature DB >> 8943980

Impact of irritable bowel syndrome on quality of life.

W E Whitehead1, C K Burnett, E W Cook, E Taub.   

Abstract

The aims of this study were to determine the impact of irritable bowel syndrome on quality of life using a well-standardized measure, the SF-36, and to determine whether apparent impairments may be due to neuroticism. Undergraduate students with irritable bowel syndrome who had consulted a physician (41 females, 42 males), students with irritable bowel who had not consulted a physician (91 females, 74 males), and asymptomatic controls (52 females, 70 males) completed questionnaires on quality of life, neuroticism, and psychological distress. Patients showed greater impairment in quality of life than nonconsulters, who in turn showed greater impairment than controls. Neuroticism and psychological distress were correlated with all quality-of-life measures. However, when neuroticism and psychological distress were statistically partialed out, irritable bowel syndrome still had a significant negative impact. The SF-36 may be a useful outcome measure in treatment studies, but investigators will need to correct for confounding influences of neuroticism.

Entities:  

Mesh:

Year:  1996        PMID: 8943980     DOI: 10.1007/bf02071408

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

Authors:  K W Heaton; L J O'Donnell; F E Braddon; R A Mountford; A O Hughes; P J Cripps
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

2.  Somatic complaints in males as a function of age and neuroticism: a longitudinal analysis.

Authors:  P T Costa; R R McCrae
Journal:  J Behav Med       Date:  1980-09

3.  Urgency and fecal soiling in people with bowel dysfunction.

Authors:  D A Drossman; R S Sandler; C M Broom; D C McKee
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

4.  Impact of functional dyspepsia on quality of life.

Authors:  N J Talley; A L Weaver; A R Zinsmeister
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

5.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Towards a better understanding of patients with irritable bowel syndrome.

Authors:  C P Dancey; S Backhouse
Journal:  J Adv Nurs       Date:  1993-09       Impact factor: 3.187

7.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

8.  Irritable bowel syndrome defined by factor analysis. Gender and race comparisons.

Authors:  E Taub; J L Cuevas; E W Cook; M Crowell; W E Whitehead
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

9.  Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples.

Authors:  W E Whitehead; L Bosmajian; A B Zonderman; P T Costa; M M Schuster
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  73 in total

1.  Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial.

Authors:  Giancarlo Parisi; Enrico Bottona; Maurizio Carrara; Fabrizio Cardin; Alessandra Faedo; Dario Goldin; Marco Marino; Maurizio Pantalena; Gianni Tafner; Giorgio Verdianelli; Maurizio Zilli; Gioacchino Leandro
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.

Authors:  Seon-Young Park; Min-Ho Park; Kyoung-Won Yoon; Sung-Bum Cho; Wan-Sik Lee; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

3.  Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

Authors:  Ji Yong Ahn; Kyung Hun Lee; Chang Hwan Choi; Ju Wan Kim; Hyun Woong Lee; Jeong Wook Kim; Mi Kyung Kim; Gui Young Kwon; Seungbong Han; Seong-Eun Kim; Sung Min Kim; Sae Kyung Chang
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

4.  Medical treatment of irritable bowel syndrome.

Authors:  Jason Reina; James W Smith
Journal:  Clin Colon Rectal Surg       Date:  2005-05

5.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

6.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

7.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

9.  The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.

Authors:  Tara J Taylor; Nader N Youssef; Ravi Shankar; David E Kleiner; Wendy A Henderson
Journal:  BMC Res Notes       Date:  2010-10-21

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.